Innoviva Investor Wins Board Seats In Chancery Proxy Suit
A shareholder of drug developer Innoviva Inc. won a battle with the company over the makeup of its board of directors Friday when a Delaware Chancery Court judge determined that a...To view the full article, register now.
Already a subscriber? Click here to view full article